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ZIKA VIRUS RNA DEGRADATION IN MUNICIPAL WASTEWATER
By
AARON L. MUIRHEAD

INTRODUCTION: Zika virus (ZIKV) resurfaced in 2015 and caused a worldwide epidemic.
ZIKV emerged as a potential cause of the serious birth defect of microcephaly, and the rare
neurological disorder Guillain-Barre syndrome. An estimated 80% of ZIKV cases are
asymptomatic, and treatment for the disease is not mandated until an infection of ZIKV is
confirmed. This has caused a challenge in determining the true burden ZIKV has on
communities that face epidemics. There has been a methodological and research gap in the
detection and recovery of enveloped viruses, such as ZIKV, in environmental waters. Recent
work has shown that ZIKV RNA is better detected in urine opposed to serum samples. This
suggest that exploration of methods to understand the detectability and survivability of ZIKV in
various waters and highlights the potential to detect it in municipal wastewater in low-resource
settings.
AIM: The objectives of this study are to develop a system for laboratory study to detect ZIKV
RNA in environmental waters and to evaluate the stability of ZIKV RNA in sewage under three
relevant temperatures.
METHODS: ZIKV MEX 1-44 was added to primary effluent from a local municipal wastewater
treatment plant. Two experiments were conducted. Experiment 1 was meant to assess the
feasibility of detecting ZIKV RNA. Samples were held at 25°C and RNA was extracted at days
0, 1, and 7. Experiment 2 consisted of samples held at 4°C, 25°C, 35°C and RNA was extracted
at days 0, 7, 14, and 29. Quantitative polymerase chain reaction (qPCR) was used to quantify
ZKV RNA concentration. A general linear mixed model was applied to account for repeated
measurements and compare groups to calculate the amount of time to virus inactivation.
RESULTS: ZIKV RNA was detected in all samples at all times and temperatures with qPCR. At
the 3 temperatures, ZIKV RNA degradation occurred over the 29 days in the 25°C and 35°C
temperature groups and was more rapid in the 35°C group. There was little to no decrease
observed in ZIKV RNA at 4°C.
DISCUSSION: ZIKV RNA is more environmentally stable than assumed. This study was a pilot
study to develop evidence for further exploration of materials and methods for detection of ZIKV
RNA in wastewater. Cost-effective methods to detect ZIKV RNA in municipal wastewater such
as this will be of crucial importance to better understand the burden ZIKV has on a community
during epidemics due to challenges faced on detecting ZIKV infections in the clinical setting.
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INTRODUCTION
Zika virus (ZIKV) was first isolated in Uganda in 1947 [1], but it was not until 2007 a
large-scale human outbreak of ZIKV was reported in Yap Island of the Federated States of
Micronesia [2]. Outbreaks since have continued worldwide, many within the country of Brazil.
The exact dissemination point of ZIKV human outbreaks in Brazil differs with some
retrospective studies suggesting that ZIKV was circulating in southern Brazil from April to
November 2013 [3-5], and others suggested the northeastern region of Brazil in February 2014
[6]. In March 2015, Brazil reported a novel outbreak to the World Health Organization [7] with
the initial reports stating symptoms were of a mild severity and tests were negative for
chikungunya, measles, rubella, parvovirus B19, and enterovirus [7]. ZIKV was not suspected at
this stage, and no tests for ZIKV were carried out. In May 2015, Brazil confirmed ZIKV virus
was circulating in the country [7] and was also later confirmed in Bahia, Brazil by the molecular
method of reverse transcription polymerase chain reaction (RT-PCR) [8]. Over the next two
years ZIKV emerged as a potential cause of the serious birth defect of microcephaly, and the rare
neurological disorder Guillain-Barre syndrome. This disease in causes the body's immune system
to accidentally attacks part of its peripheral nervous system [9, 10]. Brazil had a notable increase
in cases of microcephaly in newborns the summer of 2015. In late 2015, Brazil confirmed that
the increase was associated with ZIKV that had infected pregnant women [11].
Similar to the dengue and chikungunya viruses, ZIKV is primarily spread by the
mosquito Aedes aegypti, [1]. This domestic mosquito resides largely in tropical and sub-tropical
regions. Ecological spatial analysis revealed that the northeastern region of Brazil has the highest
risk of Aedes aegypti house infestation due to the man-made habitats best suited for larval
development [12]. Since the initial outbreak of ZIKV in Brazil in 2015, 84 countries have
discovered evidence of ZIKV transmission [13]. As of 2017, 23 countries have had increases of
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Guillain-Barre syndrome and ZKV infections; and 31 countries have had an increase in
microcephaly which was likely associated to ZIKV infection [13, 14]. Added to the current
global impact, the effects of climate change may cause the spread of ZIKV into new
geographical regions in the future [15].
There has been a methodological gap in the detection and recovery of enveloped viruses
in environmental waters. There is a long history of research that has focused on the detection and
fate of non-enveloped enteric viruses in municipal wastewater and that they are mainly
transmitted by the fecal-oral route (e.g., adenoviruses, polioviruses, enteroviruses, noroviruses
and rotaviruses) [16-19]. Due to this focus, there are well-established methods for detecting nonenveloped viruses in wastewaters. Enveloped viruses are structured differently. Enveloped
viruses have a lipid bilayer membrane that is outside of the viral protein capsid that are not
present in their non-enveloped counterparts. This layer has proven to impact their survival in
aquatic environments [20, 21]. This also means that methods developed to detect non-enveloped
viruses in wastewaters may not be ideal for detecting enveloped viruses as well. It has been
found that common organic solvents [22] used in the concentration and purification process for
non-enveloped enteric viruses are not suitable for enveloped viruses due to the sensitivity of the
lipid bilayer.
Based on the widely cited research that found ~80% of infected ZIKV patients to be
asymptomatic [2], effective methods to detect ZIKV in sewage and environmental waters will be
required to determine the burden on a community when it may not be properly assessed in
resource poor settings. Currently, surveillance efforts by the Pan American Health Organization
and World Health Organization mandate that only individuals that display ZIKV-like symptoms
undergo laboratory testing for ZIKV infection [23]. This underestimates the true prevalence of
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infection and related complications, leaving current estimations to be biased towards those who
seek care or develop symptoms to an infection [24]. Due to these potential errors in determining
true prevalence, coupled with evidence discovering that enveloped viruses are more stable in the
environment than presumed [25], developing cost effective measures to detect ZIKV burden on a
community has become more feasible.
Increasing the understanding of developing a cost-effective detection method for ZIKV
and potentially other enveloped viruses will allow resource-limited settings to assess for disease
burden during an epidemic. This study was done with following aims:
•

To develop a system for laboratory study of ZIKV RNA in environmental waters

•

To evaluate the stability of ZIKV RNA in sewage under three relevant temperatures
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Literature Review
Envelope virus survival and degradation
ZIKV’s lipid bilayer membrane outside the viral protein capsid contains glycoproteins,
which makes it an enveloped virus [20]. The various functional groups on the outer surface of
enveloped viruses compared to non-enveloped viruses, which does not have this outer
membrane, likely limits enveloped virus’ survival and partitioning behavior in liquid
environments [21, 26]. Due to this impact on the survivability, more research is needed to
understand the ability for enveloped viruses to exist in detectable concentrations outside of their
hosts in the environment. In recent years, this research has begun to address the ability of
enveloped viruses to withstand environments outside of the body. A recent review noted that the
time for 90% inactivation varied from hours to months for avian influenza (an enveloped virus)
under relevant environmental conditions; it lasted as long as some nonenveloped viruses in
similar conditions [27]. A study that compared the concentration value of Phi6, a commonly used
enveloped virus surrogate, to other enveloped viruses in numerous liquid mediums highlighted
the variability of enveloped virus’ persistence in the environment [25]. Under epidemic
conditions, wastewater facilities must increase treatment methods to avoid transmitting
enveloped viruses. Although treated wastewater does reduce viral load, enveloped viruses [10]
and other infectious human viruses [28-30] have been found to be able to survive within
wastewaters and have been detectable in wastewater treatment effluent. Also, the 2014 Ebola (an
enveloped virus) cases in the U.S. exposed how little research has been conducted surrounding
the presence and fate of enveloped viruses in human waste and sewage [31]. At the time, there
were few studies that focused on the survivability of Ebola virus outside of the human body and
few in municipal wastewater were conducted. Added to this, government agencies announced to
the public that Ebola was not contagious outside of the body and wastewater treatment
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procedures resulted in low risks of transmission. Since then, research has been initiated on the
fate of Ebola virus and Ebola virus surrogates in the environment [32, 33], and research has
found Ebola to have persisted in sterile wastewater for up to 8 days [31]. The assumption that
Ebola rapidly inactivates outside of the human body still has not been validated.

Detection of enveloped virus
Detection of non-enveloped viruses in environmental waters has been widely studied due
non-enveloped virus’ survivability but developing detection methods for non-enveloped and
enveloped viruses are not same. Methods to concentrate and recover enveloped and nonenveloped viruses differ and may not be suitable for one compared to the other. As previously
mentioned, enveloped virus’ lipid layers are sensitive to the organic solvents (i.e. sodium
deoxycholate, and phospholipase A.) [22] that are commonly used to extract and purify nonenveloped enteric viruses. Recent work may have found a more suitable method by optimized
ultrafiltration. This method yielded 18-25% recovery for two enveloped viruses in wastewater
[10]. This research also tested a ultracentrifugation method to pellet wastewater solids, and
concluded that the utilization of this method can effectively recover enveloped virus’ from
wastewater for qPCR detection [10].
Detecting ZIKV RNA in urine has increased in interest in recent years. Many studies
describe virus detection that persists for longer durations in urine than in serum [34-38]. Work
that compared test results for ZIKV RNA in different media found approximately twice as many
persons with RT-PCR positive test results for ZIKV RNA in urine specimens, 61 persons (92%),
compared with 31 persons (47%) from serum specimens respectively [39]. These studies
reiterate that the notion that sampling urine opposed to serum can increase the number of
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laboratory-confirmed cases in areas facing an epidemic because of a longer period of RNA
detection, higher RNA levels, and less invasive sample collection [38].
In laboratory settings, the detection of ZIKV in urine can be affected by many factors
including matrix-specific effects, handling, and storage of specimens. Little knowledge is known
about the stability of ZIKV RNA in urine. RNA can be prone to rapid degradation in urine
because urine is a suitable environment for a high activity of hydrolysis, up to 100 times higher
than serum [40]. To counteract this, nucleic acid stabilizers must be used to minimize RNA
degradation to slow the hydrolysis process and preserve the nucleic acids originally within the
samples [41-43]. When stored at −80 °C, a common storage temperature, ZIKV RNA in urine
samples suffered a significant loss of PCR detection without nucleic acid stabilizers [44]. At the
same temperature, the addition of nucleic acid stabilizers to urine samples significantly corrected
this effect and resulted in recovery of ZIKV RNA in all samples [44].
Wastewater epidemiology is a growing field that has had numerous studies centered on
understanding the transmission and detection of viruses, with majority focusing on nonenveloped
enteric viruses. With the increased interest and feasibility of studying detection of enveloped
viruses in environmental water, employing detection methods suitable for ZIKV is a viable
option. Considering ZKV is largely an asymptomatic disease added to the ability to detect ZKV
in urine, this provides an opportune moment to employ research that develop detection methods
for ZIKV which compensate for missing ZIKV cases in the clinical and expand the field of
wastewater epidemiology.
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Application of Multilevel modeling
Multilevel modeling is an analytical approach that is an appropriate modeling framework
for repeated measures data. Multilevel modeling can account for the within and between subject
relationship for an outcome in a repeated measures setting [45].
With the collection of longitudinal data that is formed by repeated measurements on a
sample or individual, a general linear mixed model is a type of multilevel model that accounts
for within subject correlation. The within subject correlation for repeated measurements taken
over time can be accounted for with a random effect [46]. Group effects over time can be
compared with a group x time interaction term [46]. Mixed models that include random effects
(random effects model) provides the opportunity to analyze the variance of the dependent
variable based on within- and between- group components. Then, the proportion of total variance
due to between-subject variance is quantified using the intraclass correlation coefficient (ICC)
[47].
Multilevel modeling has been applied to many aspects of epidemiology (9-11) and
sexually transmitted infections (5-8) research in recent years due to its many advantages of
determining effects on individuals effected, the communities they are located in, and the
geographical location of the community. In the medical field, multilevel modeling is applied to
medical research for patients nested within a physician’s care, departments, and hospitals.
Multilevel modeling can also be applied to microbiological experiments that have multiple
experimental variables as well as repeated measures over time.
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Materials and Methods

ZIKV MEX 1-44 was grown in mosquito cells to a concentration of 106 plaque forming

units (pfu) per ml in the laboratory of Dr. Margo Brinton. The culture was stored at −80 °C until
use. Primary effluent was collected from a local wastewater treatment plant in 1-liter plastic
bottles and stored at 4ºC prior to use. The effluent was stored up to 7 days prior to inoculation
with ZIKV.

Controlled laboratory experiments
We performed two laboratory experiments to examine the persistence of ZIKV RNA in
untreated primary effluent: one at room temperature (~25℃) and one at three controlled
temperature treatment groups: 4℃, 25℃, 35℃. In the both experiments in triplicate, we spiked
ZIKV MEX 1-44 into each sample to achieve a concentration of 105 pfu/ml in unpasteurized
primary effluent. In experiment 1, the ZIKV spiked samples were stored at room temperature
~25ºC for a period of 7 days. At day 0, 1, 3, and 7, we removed aliquots and extracted nucleic
acids. In experiment 2, the samples were stored in incubators or the refrigerator at 4 ºC, 25 ºC,
and 35 ºC. During experiment 2, we extracted nucleic acid from the samples at days 0, 7, 14, and
29. During both experiments, primary effluent that was not spiked with ZIKV was also incubated
and extracted to act as a biological control.
Nucleic acid extraction was performed using the QiaAMP Minelute Virus Spin Kit per
kit instructions. All extractions were carried out according to the manufacturer’s
recommendations and were eluted to a final volume of 50 μL containing Buffer AVE. All
samples were aliquoted into duplicate samples of 25 μL and stored in -20 ºC until qPCR was
performed.
Samples were tested for ZIKV RNA using one-step real-time reverse transcription
polymerase chain reaction (RT-RNA) assay for the qualitative detection of RNA via the
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TaqPath™ Zika Virus Kit (Fisher Scientific). RT-PCR was performed on Applied Biosystems™
7500 Real-Time PCR Systems Instrument and involved 25 μL reactions of the RT-PCR
TaqPath™ Zika Virus Kit and 2.5 μL of RNA extract. Cycling conditions were based on the
recommendations of the manufacturer and are listed in table 2. In addition to the spiked and
biological controls, a known concentration of ZIKV RNA was also included in the reactions to
act as a standard curve. Each run included a negative and positive controls for ZIKV. For
quantification, standard curves were prepared containing the target sequences with the
assumption that the ATCC RNA standard was at 105 copy number / L.

Data Analysis
For experiment 2, each replicate (A, B, C) that was in each temperature condition (4°C,
25°C, 35°C) was extracted at 4 time points (day 0, 7, 14, 29) for a total of 36 repeated measures.
For the statistical analysis, qPCR results from experiment 2 was used and a general linear mixed
model applied. Treatment group of 4°C was used as the reference category in the model. Group
by time interaction terms were included in the model to quantify comparative change. The
intraclass correlation coefficient was calculated. Analysis was completed in SAS 9.4.
Data from experiment 2 were used to fit a line for each temperature in Microsoft Excel
Version 16.6.4. The equations were then used to calculate the amount of time (days) for
𝐶

𝐶

𝐶

𝐶

𝑙𝑜𝑔10 [𝐶𝑡 ] reductions to occur at 90% (-1 𝑙𝑜𝑔10 [𝐶𝑡 ]), 99% (-2 𝑙𝑜𝑔10 [𝐶𝑡 ]), 99.9% (𝑙𝑜𝑔10 [𝐶𝑡 ]).
0

0

0

0
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Results
ZIKV RNA degradation for both experiments were assessed by qPCR. Both experiments
differed by the temperatures the samples were exposed to. The qPCR run for experiment 1 tested
samples that were held at a constant temperature (25°C) and had ZIKV RNA extracted on days
0, 1, 3, and 7. Although all samples were extracted, only days 0, 1 and 7 were analyzed via qPCR
because of time and material constraints. In experiment 2, the samples were analyzed for all
conditions and all extractions. The qPCR run for experiment 2 tested samples that were exposed
to three relevant temperatures (4°C, 25°C, 35°C) and had ZIKV RNA extracted on days 0, 7, 14,
and 29.
The results of the initial qPCR experiment are displayed in Figure 1. As shown in figure
1, the qPCR cycle on the X-axis and the RNA concentration on the y-axis. In addition to the
sample replicates, the data are also provided for the standard curve. As shown by the pink, blue,
and green lines, ZIKV RNA was detectable for all conditions initiating at cycle 18. This
corresponds to a concentration (compared to the standard) of at least 105 RNA copies or higher.
Also notable in figure 1, concentrations as low as 10 or 1 RNA copy were detectable via this
assay.
The remaining results only displayed the calculated concentrations of ZIKV RNA copies.
𝐶

Figures 2 and 3 display the ZIKV RNA 𝑙𝑜𝑔10 concentration quantity and 𝑙𝑜𝑔10 [𝐶𝑡 ] of
0

experiment 1 under constant temperature. Figures 3 and 4 display the ZIKV RNA 𝑙𝑜𝑔10
𝐶

concentration quantity and 𝑙𝑜𝑔10 [𝐶𝑡 ] of experiment 2 under the three temperatures.
0

As shown in Figures 2 and 3, the initial concentration of ZIKV RNA measured via qPCR
assay indicated higher than inoculated concentrations (estimated to be approximately 109 copies)
for time point 0 for rep A and B. This decreased almost three-fold on day 1 and was closer to the
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concentration expected. This suggests that the initial concentration measurement was in error for
day 0 for A. When comparing day 1 and day 7, ZIKV RNA concentration did not decrease
greatly over the time when stored at room temperature (both days average concentration were
105 copies).
In the second experiment, ZIKV RNA degradation demonstrated a steady decline at
25°C, going from 105 copies on day 0 to 103 copies on week 4. At 35°C, there as a more rapid
decline in ZIKV RNA degradation with 105 copies on day 0, to 102 copies on day 14, to the to
101 copies at day 29. At 4°C, on average, there was a slight increase in ZIKV RNA quantity from
baseline to slightly above baselines concentrations at day 14 in all three replicates, and
degradation was not detected until day 29 (Figure 4 and 5).

Regression coefficients were calculated within a linear regression model with mixed
effects. Interaction variables were added to the model to describe the comparative change in the
response of interest for the groups. Analysis revealed that interaction variables for time x
temperature groups 25°C and 35°C were significantly different (p < 0.05) than the time x
temperature group at 4°C (Table 3). The ICC was calculated to describe how much the data in
the same group resembles each other. With a low ICC of 0.112 and the value being closer to
zero, we can conclude that data in the same groups are not similar (Table 5).
𝐶

Regression lines were calculated in Microsoft Excel to determine 𝑙𝑜𝑔10 [𝐶𝑡 ] reductions
0

for the three temperature groups. As shown in table 4, the predicted values calculated from the
regression lines to achieve 90% (−1 𝑙𝑜𝑔10), 99% (−2 𝑙𝑜𝑔10), and 99.9% (−3 𝑙𝑜𝑔10) reduction of
ZIKV at 4°C, 25°C, and 35°C. Based on the regression line, at 4°C, it would take 123 days for a
90% reduction, 209 days for a 99% reduction, and 295 days for 99.9% reduction for ZIKV RNA
degradation. At 25°C, it would take 14 days for a 90% reduction, 28 days for a 99% reduction,
20

and 41 days for 99.9% reduction for ZIKV inactivation. At 35°C, it would take 6 days for a 90%
reduction, 13 days for a 99% reduction, and 20 days for 99.9% reduction for ZIKV inactivation
(Table 4).

Discussion of Research Questions
ZIKV is a mosquito-borne enveloped virus that rapidly spread throughout the Americas
and Caribbean in 2015. Health complications from ZIKV reached epidemic proportions in 2016.
This lead to the WHO to declare a public health emergency of global concern in the same year
[7]. Currently, ZIKV is primarily spread by Aedes mosquitoes, particularly Aedes aegypti and
Aedes albopictus [48]. Recent research has created a global map of locations that are suitable for
seasonal and year-round presence of Aedes mosquitoes, revealing that the year-round presence
are locations closest to the Equator, and seasonal presence covering a significantly larger area
[49]. These locations that face a year-round presence are a higher potential risk of the
transmission of ZIKV, and may benefit the most from a cost-effective detection method of
ZIKV. With an estimated 80% of ZIKV infections to be asymptomatic [2, 50], and symptoms
that do appear are similar to many other diseases [51], other detection methods must be
implemented in settings that face ZIKV endemics.
The diagnosis of ZIKV infection has relied heavily on the detection of ZIKV RNA or
ZIKV antibodies in serum (mostly in the clinical setting). This route has been found to be
challenging, with the detection duration of ZIKV in serum to be short lived and the possibility of
cross reactivity of ZIKV antibodies to other diseases such as dengue virus. Many reports have
shown that the detection of ZIKV in urine is longer than serum [34-38]. Little to no research has
performed on the survivability of ZIKV in waters or wastewater. Wastewater epidemiology is a
growing field, and this study adds to our understanding the potential to detect ZIKV in
wastewater. Similar to the work of Ye et al. that used model enveloped viruses, this study was
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able to detect ZIKV RNA, an enveloped virus, in spiked, untreated wastewater over weeks at
various conditions. A recent meta-analysis has found that envelope viruses can take hours and up
to weeks for a 90% virus reduction to occur in relevant environmental conditions [25].
In this study, there was a detected increase in ZIKV RNA concentration within each
replicate at 4°C at time point 0 and 7 until day 14 in Experiment 2. There was an approximate
10-fold higher concentration in the samples held at 4°C compared to 25°C. Similar results were
found when ZIKV RNA concentration was quantified to understand ZIKV stability in urine.
Within the first 48 hours, while stored at 4°C, there was little decrease in ZIKV RNA
concentration and concentrations were higher at each time point compared to samples held at
25°C [44].

Study Strengths and Limitations
The strengths of this study include the use of unpasteurized primary effluent and multiple
temperatures. This is the first study to evaluate the persistence of ZIKV RNA outside of the
clinical conditions and setting. We document ZIKV RNA persistence for weeks at high
temperatures suggesting that the ZIKV may be detectable under environmental conditions found
in many endemic settings.
The results of this study adds to the growing field of wastewater epidemiology. The
assumption that enveloped viruses rapidly inactivate outside of the human body and in aqueous
environment continues are in contrast with our findings. Utilizing wastewater samples can also
be a valuable alternative or addition to ZIKV infection data collected in the clinical setting.
There are three main limitations of this study. First, the unpastuerized wastewater was not
sourced from a location that has been exposed to a known ZIKV endemic. Second, the results of
this study cannot conclude that the detection of ZIKV RNA is associated with infectivity of
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ZIKV. Third, the quantification of ZIKV RNA concentration using qPCR is not the most ideal
method of quantification as the intention of the kit was for qualitative detection.

Recommendations of Future Findings
Future work can be done to further document the ZIKV infectivity to determine if the virus is
intact or if only the RNA persisted. This can also inform collection of wastewater samples to
further the knowledge on the detection and survivability of enveloped viruses for the field of
wastewater epidemiology. The application of this procedure with sewage samples from endemic
areas can be an area of future research for research and clinical purposes. Research can also
focus on the likelihood of infectivity of ZIKV from the detection of ZIKV RNA.
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Table 1. Sample conditions for RNA extraction.
Experiment

Temperature

Replicate

1
2

~25°C
4°C
25°C
35°C

A, B, C
A, B, C
A, B, C
A, B, C

Time of Extractions
(days)
0, 1, 3, 7
0, 7, 14, 29
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Table 2. Details of the steps and thermal cycling conditions of the samples during qPCR.
Steps

Thermal Cycling Conditions

Transcription

HOLD

50°C for 10 min

Activation

HOLD

95°C for 2 min

PCR Amplification

40 cycles

95°C for 3 sec
60°C for 30 sec
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Table 3. Parameter estimates for the general linear mixed model (*p<0.05)_
Effect
Temp
Estimate (95% CI)
DF
Intercept
0.3444 (-0.7732, 1.4621)
2
Time
-0.0079 (-0.03728, 0.02132)
28
Temp
4°C
0
Ref
Temp
25°C
-0.3441 (-1.027, 0.3387)
28
Temp
35°C
-0.6754 (-1.3583, 0.0075)
28
Time*Temp
4°C
0
Ref
Time*Temp
25°C
-0.0657 (-0.1072, -0.02428)
28
Time*Temp
35°C
-0.1554 (-0.1968, -0.1139)
28

p-value
0.316
0.5814
Ref
0.3108
0.0524
Ref
0.003*
<.0001*
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Table 4. Predicted times (in days) for 𝑙𝑜𝑔10 reductions for virus inactivation at three temperature
groups
Temp

𝐶

Reduction 𝑙𝑜𝑔10 [𝐶𝑡 ]

Time* (days)

-1 (90%)
-2 (99%)
-3 (99.9%)
-1 (90%)
-2 (99%)
-3 (99.9%)
-1 (90%)
-2 (99%)
-3 (99.9%)

123
209
295
14
28
41
6
13
20

0

4°C

25°C

35°C
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Table 5. Variance Estimates and Intracluster Correlation Coefficient
Variance Estimates
Covariance Parameters

Subject

Estimate

Intercept

Replicate

0.03572

Residual

---

0.283

𝐸𝑠𝑡𝑖𝑚𝑎𝑡𝑒 𝑜𝑓 𝐼𝐶𝐶 =

0.03572
= 0.112
0.03572 + 0.283
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Figure 1: qPCR results for the detection of ZIKV RNA from spiked sewage that was held at
25°C and extracted at day 0, 1 and 7.
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Figure 2. 𝑙𝑜𝑔10 concentration values of ZIKV RNA degradation at constant temperature of 25°C
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𝐶

Figure 3. 𝑙𝑜𝑔10 [ 𝑡 ] values of ZIKV RNA degradation at constant temperature of 25°C
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Figure 4. 𝑙𝑜𝑔10 concentration values of ZIKV RNA degradation at various temperatures of 4°C,
25°C, 35°C
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Figure 5. 𝑙𝑜𝑔10 [𝐶𝑡 ] values of ZIKV RNA degradation at various temperatures of 4°C, 25°C,
0
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Appendix
SAS 9.4 Input Code for Mixed Model Analysis
data thesis2;
input temp $ time rep $ y;
datalines;
40A0
4 7 A 0.575641
4 14 A 0.751433
4 29 A -0.19964
40B0
4 7 B 0.502817
4 14 B 0.537913
4 29 B -0.15201
40C0
4 7 C 0.413423
4 14 C 0.487973
4 29 C 0.018496
25 0 A 0
25 7 A -0.47481
25 14 A -0.91801
25 29 A -2.13049
25 0 B 0
25 7 B -0.41935
25 14 B -0.85398
25 29 B -2.01454
25 0 C 0
25 7 C -0.70911
25 14 C -1.23836
25 29 C -2.29359
35 0 A 0
35 7 A -1.46241
35 14 A -2.07631
35 29 A -4.22073
35 0 B 0
35 7 B -0.55926
35 14 B -3.2746
35 29 B -4.65993
35 0 C 0
35 7 C -2.13746
35 14 C -4.81133
35 29 C -5.27542
;
run;
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proc mixed data=thesis2;
class temp rep ;
model y = time temp time*temp / s CL;
random intercept / subject = rep s;
run;
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